Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suguru Shirotake

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
In Vivo (Athens, Greece)|May 2, 2020
Efficacy of Nivolumab Plus Ipilimumab in a Patient With Renal Cell Carcinoma Concomitant With Cardiac Metastasis: A Case ReportSuguru Shirotake, Yuta Umezawa, Takashi Okabe, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 20, 2010
[Case of primary amelanotic malignant melanoma of the female urethra]Takahiko Yoshii, Akio Horiguchi, Suguru Shirotake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2010
Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasionTakeo Kosaka, Eiji Kikuchi, Shuji Mikami, et al.
Plos One|October 22, 2014
The impact of HIF1α on the Per2 circadian rhythm in renal cancer cell linesTakashi Okabe, Megumi Kumagai, Yoshihiro Nakajima, et al.
Annals of Surgical Oncology|February 19, 2015
Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After SurgeryAkira Miyajima, Satoshi Yazawa, Takeo Kosaka, et al.
Cureus|February 10, 2025
A Case of Avelumab-Resistant Upper Urothelial Carcinoma Responding to PembrolizumabKotaro Yokota, Suguru Shirotake, Yu Miyama, et al.
International Cancer Conference Journal|July 4, 2024
Aggressive variant prostate cancer with multiple subcutaneous metastases: a case reportYusuke Hoshino, Kent Kanao, Yu Miyama, et al.
The American Journal of Pathology|January 10, 2012
Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancerSuguru Shirotake, Akira Miyajima, Takeo Kosaka, et al.
Japanese Journal of Clinical Oncology|November 6, 2009
Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancerSuguru Shirotake, Eiji Kikuchi, Kazuhiro Matsumoto, et al.
Molecular and Clinical Oncology|January 19, 2019
Early tumor shrinkage as a predictive factor of metastatic renal cell carcinoma in molecular targeted therapy: A single institutional studySuguru Shirotake, Hideyuki Kondo, Takashi Okabe, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
In Vivo (Athens, Greece)|May 2, 2020
Efficacy of Nivolumab Plus Ipilimumab in a Patient With Renal Cell Carcinoma Concomitant With Cardiac Metastasis: A Case ReportSuguru Shirotake, Yuta Umezawa, Takashi Okabe, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 20, 2010
[Case of primary amelanotic malignant melanoma of the female urethra]Takahiko Yoshii, Akio Horiguchi, Suguru Shirotake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2010
Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasionTakeo Kosaka, Eiji Kikuchi, Shuji Mikami, et al.
Plos One|October 22, 2014
The impact of HIF1α on the Per2 circadian rhythm in renal cancer cell linesTakashi Okabe, Megumi Kumagai, Yoshihiro Nakajima, et al.
Annals of Surgical Oncology|February 19, 2015
Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After SurgeryAkira Miyajima, Satoshi Yazawa, Takeo Kosaka, et al.
Cureus|February 10, 2025
A Case of Avelumab-Resistant Upper Urothelial Carcinoma Responding to PembrolizumabKotaro Yokota, Suguru Shirotake, Yu Miyama, et al.
International Cancer Conference Journal|July 4, 2024
Aggressive variant prostate cancer with multiple subcutaneous metastases: a case reportYusuke Hoshino, Kent Kanao, Yu Miyama, et al.
The American Journal of Pathology|January 10, 2012
Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancerSuguru Shirotake, Akira Miyajima, Takeo Kosaka, et al.
Japanese Journal of Clinical Oncology|November 6, 2009
Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancerSuguru Shirotake, Eiji Kikuchi, Kazuhiro Matsumoto, et al.
Molecular and Clinical Oncology|January 19, 2019
Early tumor shrinkage as a predictive factor of metastatic renal cell carcinoma in molecular targeted therapy: A single institutional studySuguru Shirotake, Hideyuki Kondo, Takashi Okabe, et al.
Pageof 9